Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670.

[1]  J. D. Elliott,et al.  Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670. , 1995, The Journal of pharmacology and experimental therapeutics.

[2]  J. D. Elliott,et al.  Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs. , 1994, The Journal of pharmacology and experimental therapeutics.

[3]  J. D. Elliott,et al.  Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[4]  J. Robinette,et al.  Effects of ANG II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction. , 1994, The American journal of physiology.

[5]  S. Douglas,et al.  SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Brooks,et al.  Characterization of canine renal endothelin receptor subtypes and their function. , 1994, The Journal of pharmacology and experimental therapeutics.

[7]  V. Kon,et al.  Divergent expression of EtA and EtB receptors in response to cyclosporine in mesangial cells. , 1994, The American journal of pathology.

[8]  R. N. Garrison,et al.  Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1. , 1993, Surgery.

[9]  J. Conger,et al.  Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. , 1993, The Journal of clinical investigation.

[10]  C. Thiemermann,et al.  Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat , 1993, British journal of pharmacology.

[11]  D. Pollock,et al.  Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. , 1993, The American journal of physiology.

[12]  T. Inagami,et al.  Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. , 1992, Kidney international.

[13]  S. Takahara,et al.  FK506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells. , 1992, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  T. Bunchman,et al.  Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. , 1991, The Journal of clinical investigation.

[15]  N. Perico,et al.  INCREASED URINARY EXCRETION OF ENDOTHELIN‐1 AND ITS PRECURSOR, BIG‐ENDOTHELIN-1, IN RATS CHRONICALLY TREATED WITH CYCLOSPORINE , 1991, Transplantation.

[16]  T. Inagami,et al.  Cyclosporine promotes glomerular endothelin binding in vivo. , 1991, Journal of the American Society of Nephrology : JASN.

[17]  D. Brooks,et al.  Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number. , 1991, European journal of pharmacology.

[18]  D. Brooks,et al.  Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. , 1990, European journal of pharmacology.

[19]  N. Perico,et al.  Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. , 1990, Journal of the American Society of Nephrology : JASN.

[20]  T. Inagami,et al.  Role of endothelin in cyclosporine-induced glomerular dysfunction. , 1990, Kidney international.

[21]  H. Nakahama,et al.  Stimulatory effect of cyclosporine A on endothelin secretion by a cultured renal epithelial cell line, LLC-PK1 cells. , 1990, European journal of pharmacology.